Clinical Trial Update: Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for treatment of acute graft-versus-host disease (BMT CTN 0302) completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Graft vs Host Disease, Immune System Disorders | Phase 2 | Status: COMPLETED | Results posted: 2010-04-09